Patients treated with drugs targeting the epidermal growth factor receptor (EGFR) frequently develop acneiform skin toxicities. These skin reactions can impair treatment adherence and clinical outcome. Prophylactic treatment with doxycycline reduces the severity of skin toxicities. ...